Tel: +61 3 990 39035
Fax: +61 3 990 39629
Email: David.Kong@monash.edu
Web: http://www.pharm.monash.edu.au/research/cmus/index.html
Position
Lecturer
Faculty of Pharmacy and Pharmaceutical Sciences
Centre for Medicine Use and Safety
Duguid, M., Kong, D.C.M., 2011, The role of the pharmacy service, in Antimicrobial stewardship in Australian hospitals, eds Margaret Duguid and Marilyn Cruickshank, Australian Commission of Safety and Quality in Health Care, Sydney Australia, pp. i-208.
Haas, S.J., Thien, F., Tonkin, A.M., Kong, D.C.M., Nelson, M.R., Demos, L.L., Zimmet, H.S., Krum, H., Liew, D.Y.H., McNeil, J.J., 2009, Clozapine-associated myocarditis and cardiomyopathy - It's the heart that is important, not the classification, in Cardiomyopathies, Effects and Treatments, eds Peter H. Bruno & Matthew T. Giordano, Nova Science Publishers, New York, pp. 251-283.
Hasan, S., Sulieman, H., Chapman, C.B., Stewart, K., Kong, D.C.M., 2012, Community pharmacy services in the United Arab Emirates, International Journal of Pharmacy Practice [P], vol 20, John Wiley & Sons, United Kingdom, pp. 218-225.
Chan, E.W., Knott, J.C., Liew, D., Taylor, D.M., Kong, D.C.M., 2012, Cost-minimisation analysis of midazolam versus droperidol for acute agitation in the emergency department, Journal of Pharmacy Practice and Research [P], vol 42, issue 1, Society of Hospital Pharmacists of Australia, Collingwood VIC Australia, pp. 11-16.
Chan, E.W., Kong, D.C.M., Knott, J.C., Castle, D.J., 2012, Ethical issues in researching interventions for behavioral disturbance in psychotic disorders, Asia-Pacific Psychiatry [P], vol 4, issue 2, Wiley-Blackwell, Malden Massachusetts USA, pp. 140-143.
Heng, S.C., Slavin, M., Chen, S.C.A., Heath, C., Nguyen, Q., Billah, M.B., Nation, R.L., Kong, D.C.M., 2012, Hospital costs, length of stay and mortality attributable to invasive scedosporiosis in haematology patients, Journal of Antimicrobial Chemotherapy [E], vol 67, issue 9, Oxford University Press, Oxford UK, pp. 2274-2282.
Neoh, C.F., Kong, D.C.M., Slavin, M., Chen, S.C.A., 2012, Pharmacological and host considerations surrounding dose selection and duration of therapy with echinocandins, Current Fungal Infection Reports [P], vol 6, issue 2, Springer Healthcare, Philadelphia, Pennsylvania USA, pp. 95-106.
Neoh, C.F., Jacob, J., Leung, L., Li, J., Stathopoulos, A., Stewart, K., Kong, D.C.M., 2012, Stability of extemporaneously prepared 0.5-percent caspofungin eye drops: a potential cost-savings exercise, Antimicrobial Agents and Chemotherapy [E], vol 56, issue 6, American Society for Microbiology, Washington DC USA, pp. 3435-3437.
Lim, C.J., McLellan, S.C., Cheng, A.C., Culton, J.M., Parikh, S., Peleg, A.Y., Kong, D.C.M., 2012, Surveillance of infection burden in residential aged care facilities, Medical Journal Of Australia [P], vol 196, issue 5, Australasian Medical Publishing Company Pty. Ltd, Australia, pp. 327-331.
Chan, E.W., Taylor, D.M., Knott, J.C., Liew, D., Kong, D.C.M., 2012, The pharmacoeconomics of managing acute agitation in the emergency department: what do we know and how do we approach it?, Expert Review of Pharmacoeconomics and Outcomes Research [P], vol 12, issue 5, Expert Reviews Ltd, London UK, pp. 589-595.
Neoh, C., Snell, G., Kotsimbos, A., Levvey, B., Morrissey, C., Slavin, Stewart, K., Kong, D., 2011, Antifungal prophylaxis in lung transplantation-a world-wide survey, American Journal of Transplantation [E], vol 11, issue 2, Wiley-Blackwell Publishing, Inc., United States, pp. 361-366.
Hasan, S., Sulieman, H., Chapman, C., Stewart, K., Kong, D., 2011, Community pharmacy in the United Arab Emirates: Characteristics and workforce issues, International Journal of Pharmacy Practice [P], vol 19, issue 6, Royal Pharmaceutical Society of Great Britain, Wiley, UK, pp. 392-399.
Neoh, C., Liew, D., Slavin, M., Marriott, D., Chen, S., Morrissey, O., Stewart, K., Kong, D., 2011, Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis, Journal Of Antimicrobial Chemotherapy [P], vol 66, Oxford University Press, England, pp. 1906-1915.
Kong, D., Shuttleworth, P., Bailey, M., Grigg, A., 2011, CsA 2-h concentration correlates best with area under the concentration-time curve after allo-SCT compared with trough CsA, Bone Marrow Transplantation [P], vol E, Nature Publishing Group, United Kingdom, pp. 1-6.
Bergen, P., McDowell, J., Elliott, R., Roller, L., Kong, D., 2011, Development of an online pharmaceutical calculations learning module, Pharmacy Education [P], vol 11, issue 1, Taylor & Francis Health Sciences, England, pp. 21-25.
Williams, M., Peterson, G., Tenni, P., Bindoff, I., Curtain, C., Hughes, J., Bereznicki, L., Jackson, S., Kong, D., Hughes, J., 2011, Drug-related problems detected in Australian community pharmacies: The PROMISe trial, DICP : the annals of pharmacotherapy [P], vol 45, Harvey Whitney Books Co, United States, pp. 1067-1076.
Chan, E., Knott, J., Taylor, D., Kong, D., Knott, J., 2011, Intravenous olanzapine for acute agitation in the emergency department, Journal of Pharmacy Practice and Research [P], vol 41, issue 2, Society of Hospital Pharmacists of Australia., Australia, pp. 135-137.
Neoh, C., Leung, L., Misra, A., Vajpayee, R.B., Davies, G.E., Fullinfaw, R., Stewart, K., Kong, D.C., 2011, Penetration of topically administered 0.5-percent caspofungin eye drops into human aqueous humor, Antimicrobial Agents And Chemotherapy [P], vol 55, issue 4, American Society for Microbiology, USA, pp. 1761-1763.
Al-Badriyeh, D., Liew, D., Stewart, K., Kong, D., 2011, Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia, Mycoses [P], vol E, Grosse Verlag, Germany, pp. 1-13.
Pang, R., Kong, D., deClifford, J., Lam, S., Leung, B., 2011, Smart infusion pumps reduce intravenous medication administration errors at an Australian teaching hospital, Journal of Pharmacy Practice and Research [P], vol 41, issue 3, Society of Hospital Pharmacists of Australia., Australia, pp. 192-195.
Chen, A., Khumra, S., Eaton, V., Kong, D., 2011, Snapshot of barriers to and indicators for antimicrobial stewardship in Australian hospitals., Journal of Pharmacy Practice and Research [P], vol 41, issue 1, Society of Hospital Pharmacists of Australia., Australia, pp. 37-41.
Neoh, C., Leung, L., Vajpayee, R., Stewart, K., Kong, D., 2011, Treatment of alternaria keratitis with intrastromal and topical caspofungin in combination with intrastromal, topical, and oral voriconazole, Annals Of Pharmacotherapy [P], vol 45, Harvey Whitney Books Co, USA, pp. e24-e31.
Chan, E., Taylor, D., Knott, J., Kong, D., 2011, Variation in the management of hypothetical cases of acute agitation in Australasian emergency departments, EMA - Emergency Medicine Australasia [E], vol 23, issue 1, Wiley-Blackwell Publishing Asia, Australia, pp. 23-32.
Stuchbery, P., Kong, D.C.M., DeSantis, G., Lo, S., 2010, Clinical pharmacy workload in medical and surgical patients: effect of patient partition, disease complexity and major disease category, International Journal of Pharmacy Practice [P], vol 18, Wiley Blackwell Publishing Ltd, United Kingdom, pp. 159-166.
Al-Badriyeh, D.M., Neoh, C.F., Stewart, K., Kong, D.C.M., 2010, Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis, Clinical Ophthalmology [E], vol 4, Dove Medical Press Ltd, United Kingdom, pp. 391-405.
Al-Badriyeh, D.M., Slavin, M., Liew, D., Thursky, K., Downey, M., Grigg, A., Bajel, A., Stewart, K., Kong, D.C.M., 2010, Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia, Journal Of Antimicrobial Chemotherapy [P], vol 65, Oxford University Press, United Kingdom, pp. 1052-1061.
Al-Badriyeh, D., Heng, S., Neoh, C., Slavin, M., Stewart, K., Kong, D., 2010, Pharmacoeconomics of voriconazole in the management of invasive fungal infections, Expert Review of Pharmacoeconomics and Outcomes Research [P], vol 10, issue 6, Expert Reviews Ltd., United Kingdom, pp. 623-636.
Neoh, C.F., He, F.H., Li, J., Fullinfaw, R., Leung, L., Misra, A., Vajpayee, R., Davies, G.E., Stewart, K., Kong, D.C.M., 2010, Rapid and sensitive liquid chromatography/mass spectrometry assay for caspofungin in human aqueous humor, Antimicrobial Agents And Chemotherapy [P], vol 54, issue 10, American Society for Microbiology, United States, pp. 4467-4470.
Chen, A.W., Khumra, S., Eaton, V., Kong, D.C.M., 2010, Snapshot of antimicrobial stewardship in Australian hospitals, Journal of Pharmacy Practice and Research [P], vol 40, issue 1, Society of Hospital Pharmacists of Australia, Australia, pp. 19-25.
Al-Badriyeh, D.M., Liew, D., Stewart, K., Kong, D.C.M., 2009, Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia, Journal Of Antimicrobial Chemotherapy [P], vol 63, issue 1, Oxford University Press, United Kingdom, pp. 197-208.
Al-Badriyeh, D.M., Liew, D., Stewart, K., Kong, D.C.M., 2009, Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia, Journal Of Antimicrobial Chemotherapy [P], vol 63, issue 6, Oxford University Press, United Kingdom, pp. 1276-1285.
Chan, E.W., Knott, J.C., Taylor, D.M., Phillips, G., Kong, D.C.M., 2009, Intravenous olanzapine - another option for the acutely agitated patient, Emergency Medicine Australasia (Print) [P], vol 21, issue 3, Wiley-Blackwell Publishing Asia, Australia, pp. 241-242.
Lau, D., Leung, L., Ferdinands, M., Allen, P.J., Fullinfaw, R., Davies, G., Kong, D.C.M., 2009, Penetration of 1% voriconazole eye drops into human vitreous humour: a prospective, open-label study, Clinical And Experimental Ophthalmology [P], vol 37, issue 2, Wiley-Blackwell Publishing Asia, Australia, pp. 197-200.
Al-Badriyeh, D.M., Leung, L., Roydhouse, T., Fullinfaw, R., Daniell, M., Davies, G., Stewart, K., Kong, D.C.M., 2009, Prospective open-label study of the administration of two-percent voriconazole eye drops, Antimicrobial Agents And Chemotherapy [P], vol 53, issue 7, American Society for Microbiology, United States, pp. 3153-3155.
Al-Badriyeh, D.M., Li, J., Stewart, K., Kong, D.C.M., Leung, L., Davies, G., Fullinfaw, R., 2009, Stability of extemporaneously prepared voriconazole ophthalmic solution, American Journal of Health-System Pharmacy [P], vol 66, issue 16, American Journal of Health-System Pharmacists, United States, pp. 1478-1483.
Al-Badriyeh, D.M., Leung, L., Davies, G., Stewart, K., Kong, D.C.M., 2009, Successful salvage treatment of scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin, Annals Of Pharmacotherapy [P], vol 43, issue 6, Harvey Whitney Books Company, United States, pp. 1139-1142.
Al-Badriyeh, D.M., Leung, L., Davies, G., Stewart, K., Kong, D.C.M., 2009, Successful use of topical voriconazole 1% alone as first-line antifungal therapy against candida albicans keratitis, Annals Of Pharmacotherapy [P], vol 43, issue 12, Harvey Whitney Books Company, United States, pp. 2103-2107.
Hassali, A.A., Stewart, K., Kong, D.C.M., 2008, A national survey on knowledge and perceptions of senior medical students in Australia about generic medicines, Medical Journal of Australia, vol 188, issue 2, Australasian Medical Publishing Company Pty Ltd, Australia, pp. 123-124.
Stuchbery, P., Kong, D.C.M., DeSantis, G., Lo, S., 2008, Determining Clinical Pharmacy Workload by Patient Disease Classification in Medical and Surgical Patients, Journal of Pharmacy Practice and Research, vol 38, issue 2, Society of Hospital Pharmacists of Australia, Australia, pp. 126-131.
Vuong, T., Marriott, J.L., Kong, D.C.M., Siderov, J., 2008, Implementation of a community liaison pharmacy service: a randomised controlled trial, International Journal of Pharmacy Practice, vol 16, issue 0, Pharmaceutical Press, United Kingdom, pp. 127-135.
Sudhakaran, S., Rayner, C.R., Li, J., Kong, D.C.M., 2008, Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus, British Journal of Clinical Pharmacology, vol 65, issue 5, Wiley-Blackwell Publishing Ltd, United Kingdom, pp. 667-673.
Worth, L.J., Blyth, C.C., Booth, D.L., Kong, D.C.M., Marriott, D., Cassumbhoy, M., Ray, J., Slavin, M., Wilkes, J.R., 2008, Optimizing antifungal drug dosing and monitoring to avoid toxicity and improve outcomes in patients with haematological disorders, Internal Medicine Journal, vol 38, issue 6b, Wiley-Blackwell Publishing Asia, Australia, pp. 521-537.
Lau, D., Fedinands, M., Leung, L., Fullinfaw, R., Kong, D.C.M., Davies, G., Daniell, M., 2008, Penetration of voriconazole, 1%, eyedrops into human aqueous humor: A prospective open-label study, Archives of Ophthalmology, vol 126, issue 3, Springer, Germany, pp. 343-346.
Camerino, M.A., Kong, D.C.M., Chalmers, D.K., Thompson, P., 2008, Solid phase synthesis and circular dichroism analysis of (i -> i + 4) cyclic lactam analogues of kisspeptin, International Journal of Peptide Research and Therapeutics, vol 14, issue 4, Springer, Netherlands, pp. 323-331.
To, T., Ellis, A.G., Ching, M.S., Shilson, A.D., Kong, D.C.M., Garrett, K., 2008, Stability of a formulated N-acetylcysteine capsule for prevention of contrast-induced nephropathy, Journal of Pharmacy Practice and Research, vol 38, issue 3, Society of Hospital Pharmacists of Australia, Australia, pp. 219-222.
Hassali, M.A., Kong, D.C.M., Stewart, K., 2007, A comparison between senior medical students' and pharmacy pre-registrants' knowledge and perceptions of generic medicines, Medical Education, vol 41, issue 7, Blackwell Publishing, England, pp. 703-710.
George, J., Kong, D.C.M., Stewart, K., 2007, Adherence to disease management programs in patients with COPD, International Journal of Chronic Obstructive Pulmonary Disease, vol 2, issue 3, Dove Medical Press Limited, New Zealand, pp. 253-262.
Sudhakaran, S., Rayner, C.R., Li, J., Kong, D.C.M., Gude, N.M., Nation, R.L., 2007, Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma, British Journal of Clinical Pharmacology, vol 63, issue 3, Blackwell Publishing Ltd, UK, pp. 315-321.
Stuchbery, P., Kong, D.C.M., DeSantis, G.N., Lo, S.K., 2007, Identification by observation of clinical pharmacists' activities in a hospital inpatient setting, Pharmacy Practice, vol 5, issue 1, Centro de Investigaciones y Publicaciones Farmaceuticas, Spain, pp. 10-16.
Hassali, M.A., Kong, D.C.M., Stewart, K., 2007, Knowledge and perceptions of recent pharmacy graduates about generic medicines, Pharmacy Education, vol 7, issue 1, Informa Healthcare, UK, pp. 89-95.
Stuchbery, P., Kong, D.C.M., DeSantis, G.N., Lo, S.K., 2007, Measuring the time required to provide components of clinical pharmacy services, Journal of Pharmacy Practice and Research, vol 37, issue 2, Society of Hospital Pharmacists of Australia, Australia, pp. 102-107.
George, J., Kong, D.C.M., Santamaria, N.M., Ioannides-Demos, L.L., Stewart, K., 2006, Adherence to disease management interventions for COPD patients: patients' perspectives, Journal of Pharmacy Practice and Research, vol 36, issue 4, Society of Hospital Pharmacists of Australia, South Melbourne VIC Australia, pp. 278-285.
George, J., Mackinnon, A., Kong, D.C.M., Stewart, K., 2006, Development and validation of the Beliefs and Behaviour Questionnaire (BBQ), Patient Education and Counseling, vol 64, issue 1-3, Elsevier Ireland Ltd, Ireland, pp. 50-60.
George, J., Vuong, T., Bailey, M.J., Kong, D.C.M., Marriott, J.L., Stewart, K., 2006, Development and validation of the Medication-Based Disease Burden Index, The Annals of Pharmacotherapy, vol 40, issue 4, Harvey Whitney Books Company, Cincinnati USA, pp. 645-650.
Larizza, M.A., Dooley, M.J., Stewart, K., Kong, D.C.M., 2006, Factors influencing adherence to molecular therapies in haematology-oncology outpatients, Journal of Pharmacy Practice and Research, vol 36, issue 2, Society of Hospital Pharmacists of Australia, Australia, pp. 115-118.
Hassali, M.A., Kong, D.C.M., Stewart, K., 2006, Generic medicines: perceptions of general practitioners in Melbourne, Australia, Journal of Generic Medicines, vol 3, issue 3, Palgrave Macmillan Ltd, UK, pp. 214-225.
George, J., Vuong, T., Bailey, M.J., Kong, D.C.M., Marriott, J.L., Stewart, K., 2006, Medication regimen complexity and adherence in patients at risk of medication misadventure, Journal of Pharmacy Practice and Research, vol 36, issue 2, Society of Hospital Pharmacists of Australia, Australia, pp. 99-102.
Kong, D.C.M., 2006, Medication safety issues - 3, Malaysian Journal of Pharmacy, vol 1, issue 5, Malayasian Pharmaceutical Society, Malayasia, pp. 154-161.
George, J., Kong, D.C.M., Santamaria, N.M., Ioannides-Demos, L.L., Stewart, K., 2006, Smoking cessation: COPD patients' perspective, Journal of Pharmacy Practice and Research, vol 36, issue 2, Society of Hospital Pharmacists of Australia, South Melbourne Vic Australia, pp. 107-110.
Sudhakaran, S., Ghabrial, H., Nation, R.L., Kong, D.C.M., Gude, N.M., Angus, P.W., Rayner, C.R., 2005, Differential bidirectional transfer of Indinavir in the isolated perfused human placenta, Antimicrobial Agents and Chemotherapy, vol 49, issue 3, American Society for Microbiology, USA, pp. 1023-1028.
George, J., Kong, D.C.M., Thoman, R., Stewart, K., 2005, Factors associated with medication nonadherence in patients with COPD, Chest: the cardiopulmonary and critical care journal, vol 128, issue 5, American College of Chest Physicians, USA, pp. 3198-3204.
Hassali, M.A., Kong, D.C.M., Stewart, K., 2005, Generic Medicines: Perceptions of Community Pharmacists in Melbourne, Australia, Journal of Research in Pharmaceutical Economics [P], vol 14, issue 3, Pharmaceutical Products Press, USA, pp. 27-45.
Ahmad Hassali, M.A., Kong, D.C.M., Stewart, K., 2005, Generic medicines: perceptions of consumers in Melbourne, Australia, International Journal of Pharmacy Practice, vol 13, Pharmaceutical Press, UK, pp. 257-264.
George, J., Phun, Y., Bailey, M.J., Kong, D.C.M., Stewart, K., 2004, Development and validation of the Medication Regimen Complexity Index, The Annals of Pharmacotherapy, vol 38, issue 9, Harvey Whitney Books Company, USA, pp. 1369-1376.
Yuriev, E., Kong, D.C.M., Iskander, M.N., 2004, Investigation of structure-activity relationships in a series of glibenclamide analogues, European Journal of Medicinal Chemistry, vol 39, issue 10, Editions Scientifiques Medicales Elsevier, Paris France, pp. 835-847.
Levy, R.W., Rayner, C.R., Fairley, C.K., Kong, D.C.M., Mijch, A.M., Costello, K., McArthur, C., 2004, Multidisciplinary HIV adherence intervention: A randomized study, AIDS Patient Care and STDs, vol 18, issue 12, Mary Ann Liebert, Inc. Publishers, USA, pp. 728-735.
George, J., Ioannides-Demos, L.L., Santamaria, N.M., Kong, D.C.M., Stewart, K., 2004, Use of complementary and alternative medicines by patients with chronic obstructive pulmonary disease, Medical Journal of Australia, vol 181, issue 5, Australasian Medical Publishing Co Pty Ltd, Australia, pp. 248-251.
Ahmad Hassali, M.A., Kong, D.C.M., Stewart, K., 2004, Utilisation of generic medicines in the Australian healthcare system, Journal of Generic Medicines, vol 2, issue 1, Henry Stewart Publications, London UK, pp. 42-52.
Fairley, C.K., Levy, R., Rayner, C.R., Allardice, K., Costello, K., Thomas, C., McArthur, C., Kong, D.C.M., Mijch, A.M., 2003, Randomized trial of an adherence programme for clients with HIV, International Journal of STD & AIDS, vol 14, issue 12, Royal Society of Medicine Press Ltd, UK, pp. 805-809.
Snell, G.I., Kotsimbos, T.C., Levvey, B., Skiba, M.A., Rutherford, D., Kong, D.C.M., Williams, T.J., Krum, H., 2000, Pharmacokinetic assessment of oral ganciclovir in lung transplant recipients with cystic fibrosis, Journal of Antimicrobial Chemotherapy, vol 45, British Society for Antimicrobial Chemotherapy, UK, pp. 511-516.
Kong, D.C.M., Von Itzstein, M., 1998, The chemoenzymatic synthesis of 9 - substituted 3,9 - dideoxy - D- glycero - D - galacto - 2 - nonulosonic acids, Carbohydrate Research, vol 305, Elsevier Science, New York NY USA, pp. 323-329.
Wu, W., Jin, B., Kong, D.C.M., Von Itzstein, M., 1997, A facile synthesis of a useful 5 - N - substituted -3,5 - dideoxy - D - glycero - D - galacto - 2 - nonulosonic acid from 2 - acetamido - 2 - deoxy - D - glucose, Carbohydrate Research, vol 300, Elsevier Science, UK, pp. 171-174.
Terada, T., Kitajima, K., Inoue, S., Wilson, J.C., Norton, A.K., Kong, D.C.M., Thomson, R.J., Von Itzstein, M., Inoue, Y., 1997, Catalysis by a new sialidase, deamineuraminic acid residue - cleaving enzyme (KNDNase,Sm), initially forms a less stablea - anomer of 3 - Deoxy - D -glycero galacto - nonulosonic acid and is strongly inhibited by the transition state analogue, 2 - De, Journal of Biological Chemistry, vol 272, Am Society for Biochemistry and Molecular Biology, USA, pp. 5452-5456.
McPherson, G.A., Choi, R.T., Kong, D.C., Iskander, M.N., 1997, The thromboxane A2 and K ATP channel antagonist actions of a series of shulphonylurea derivatives in the pig coronary artery, European Journal of Pharmacology, vol 324, Elsevier Science Ltd, UK, pp. 193-200.
McPherson, G.A., Choi, R.T., Kong, D.C., Iskander, M.N., 1997, The thromboxane A2 and Katp channel antagonist actions of a series of sulphonylurea derivatives in the pig coronary artery, European Journal of Pharmacology, vol 324, Elsevier, Netherland, pp. 193-200.
Gilbert, K., Chung, C., Wong, Y., Kong, D., 2010, Communication for Pharmacy Practice: Exploring a priori concepts of communication in a 1st Year Pharmacy Lecture across Australia and Malaysia, Medical Education (Japan) 2010 Supplement: 42nd Annual Congress of the Japan Society for Medical Education, Shinohara Publications, Tokyo, Japan, p. 137.
Affiliations with research centres
Centre for Medicine Use and Safety
Authorised by: Director, Office of Marketing and Communications.
Maintained by: eSolutions ServiceDesk.
Last updated: 18 February 2013.
Copyright © 2013 Monash University. ABN 12 377 614 012 -
Accessibility -
Caution -
Privacy
CRICOS Provider Number: 00008C
We acknowledge and pay respects to the Elders and Traditional Owners of the land on which our six Australian campuses stand. Information for Indigenous Australians
